Frequently Asked Questions

Early studies suggest potential applications in metabolism and cellular energy, but evidence is limited to preliminary research.
It is typically provided as a subcutaneous injection.
SLU-PP-332 is an investigational peptide currently in early research for its potential role in metabolic health.
Possible side effects may include injection site irritation, headache, or fatigue. Report any concerning reactions to your provider  
Areas of research include immune balance, resilience, and healthy aging. Evidence is preliminary, and it is not FDA-approved for these uses.
Thymulin is usually administered as a subcutaneous injection.
Thymulin is a thymic peptide being studied for its potential role in immune function.
Possible side effects may include temporary redness or irritation at the application or injection site. Systemic effects are rare.  
Research includes its potential effects on skin elasticity, wound healing, and hair health. Evidence is preliminary, and it is not FDA-approved for these uses.
It may be provided in topical, injectable, or oral forms depending on the protocol. Your provider will guide the best option for you.
Copper Tripeptide is a naturally occurring copper peptide that has been studied for its potential role in skin and tissue health.
Side effects may include gastrointestinal upset, injection site irritation, or rare allergic reactions. Report any concerning symptoms to your provider.